Targeted therapies and thyroid cancer: an update

被引：5
|
作者：
de la Fouchardiere, Christelle [1 ]
Droz, Jean-Pierre [1 ]
机构：
[1] Univ Lyon 1, Ctr Leon Berard, F-69008 Lyon, France
来源：
ANTI-CANCER DRUGS | 2011年 / 22卷 / 07期
关键词：
anaplastic thyroid carcinoma; differentiated thyroid carcinoma; medullary thyroid carcinoma; targeted therapy; PHASE-II TRIAL; TYROSINE KINASE INHIBITORS; ADVANCED MEDULLARY; ALTERNATING COMBINATION; PROGNOSTIC-FACTORS; CARCINOMA; SORAFENIB; SUNITINIB; EFFICACY; GROWTH;
D O I：
10.1097/CAD.0b013e32834319c7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment of metastatic, progressive thyroid cancer has evolved over recent years. New 'targeted' therapeutic approaches have been developed along with advances in the knowledge of thyroid carcinogenesis and the identification of tumor and endothelial targets. In recent years, results of targeted therapies have shown some benefit in refractory, progressive, differentiated, and medullary thyroid carcinomas but not, until recently, in undifferentiated thyroid carcinoma. We review here the different targeted therapies tested in thyroid cancers. Anti-Cancer Drugs 22: 688-699 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码：688 / 699
页数：12
相关论文
共 50 条
  • [41] HER2-targeted therapies beyond breast cancer - an update
    Yoon, Jeesun
    Oh, Do-Youn
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (09) : 675 - 700
  • [42] Targeted molecular therapies for ovarian cancer: An update and future perspectives (Review)
    Shigetomi, Hiroshi
    Higashiura, Yumi
    Kajihara, Hirotaka
    Kobayashi, Hiroshi
    ONCOLOGY REPORTS, 2012, 28 (02) : 395 - 408
  • [43] Rearranged during transfection (RET) lung cancer - Update on targeted therapies
    Mullally, W. J.
    O'Leary, C. G.
    O'Byrne, K. J.
    LUNG CANCER, 2025, 200
  • [44] Molecular targeted therapies in head and neck cancer - An update of recent developements -
    Goerner, Martin
    Seiwert, Tanguy Y.
    Sudhoff, Holger
    HEAD & NECK ONCOLOGY, 2010, 2
  • [45] Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians
    Rolfo, Christian
    Passiglia, Francesco
    Ostrowski, Marcin
    Farracho, Lucia
    Ondoichova, Tereza
    Dolcan, Ana
    Castiglia, Marta
    Remmen, Roy
    Papadimitriou, Konstantinos
    Pauwels, Patrick
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2015, 28 (01) : 124 - 133
  • [46] Mechanisms of resistance to molecular targeted therapies in breast cancer: update and future
    Magne, N.
    Chargari, C.
    Conforti, R.
    Toillon, R. -A.
    Bauduceau, O.
    Vedrine, L.
    Khayat, D.
    Spano, J. -P.
    BULLETIN DU CANCER, 2010, 97 (03) : 385 - 395
  • [47] Update on Gastroesophageal Adenocarcinoma Targeted Therapies
    Maron, Steven B.
    Catenacci, Daniel V. T.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (03) : 511 - +
  • [48] Targeted therapies in diabetic nephropathy: an update
    Gupta, Ankur
    Gupta, Preeti
    Biyani, Mohan
    JOURNAL OF NEPHROLOGY, 2011, 24 (06) : 686 - 695
  • [49] Novel targeted therapies in chordoma: an update
    Di Maio, Salvatore
    Yip, Stephen
    Al Zhrani, Gmaan A.
    Alotaibi, Fahad E.
    Al Turki, Abdulrahman
    Kong, Esther
    Rostomily, Robert C.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 873 - 883
  • [50] Novel Inhibitor-Based Therapies for Thyroid Cancer-An Update
    Ratajczak, Maciej
    Gawel, Damian
    Godlewska, Marlena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
12345